One tablet contains:
active substance – ferrous 1.5 H2O (in the form of ferrous (II) sulfate) 256.30 mg (equivalent iron) 80.0 mg,
excipients: ascorbic acid 30.0 mg, mucoprotease (anhydrous) 80.0 mg, potato starch 2.0 mg, eudragit S (copolymer of methacrylic acid and methyl methacrylate) 20.84 mg, triethyl citrate 20.08 mg, povidone 17.0 mg, talc 22.0 mg, magnesium stearate 2.0 mg, hydrogenated castor oil 6.5 mg, magnesium trisilicate up to 495.0 mg
active substance – folic acid 0.350 mg,
excipients: sodium bicarbonate 0.25 mg, talc 7.0 mg, titanium dioxide 16.0 mg, Carnauba wax 0.208 mg, Eudragit E (butylated methacrylate copolymer base) 2.50 mg, sucrose 710.0 mg
Indications for use
Prevention and treatment of iron / folate deficiency anemia
Latent iron deficiency and / or concurrent folic acid deficiency in children over 6 years of age, adults, as well as in women during pregnancy and lactation.
Methods of administration and dosage
The dose and duration of treatment are selected individually under the control of the level of hemoglobin and iron in the blood serum.
Children from 6 to 10 years old: 1 tablet per day.
Adults and children over 10 years of age: 1-2 tablets per day, immediately before taking or during meals, with water.
Prevention of iron and folic acid deficiency, treatment of moderate anemia during pregnancy – 1 tablet per day.
Treatment of severe iron / folate deficiency anemia – 1 tablet 2 times a day before meals.
For lactating women – 1 tablet during the entire lactation period.
The therapy is carried out until the peripheral blood picture normalizes (4-6 weeks).
Treatment should continue after the recovery of hemoglobin parameters in a dose of 1 tablet a day before breakfast for 1-3 months.
darkening of feces, which has no clinical significance
– pain in the epigastric region
– hypersensitivity to drug components
– hemolytic anemia
– aplastic anemia
– megaloblastic anemia associated with vitamin B12 deficiency
Since iron ions reduce the absorption of tetracyclines and penicillamine from the gastrointestinal tract, the simultaneous use of Gyno-Tardiferon® and these drugs should be avoided.
Due to a decrease in the absorption of iron when taking antacids (calcium-, aluminum- and magnesium-containing products), the interval between taking them and Gyno-Tardyferon® should be at least 2 hours.
Gyno-Tardyferon® can be prescribed to patients with diabetes mellitus, since the amount of sucrose contained in the drug shell does not affect the total blood sugar level.
When taking the drug, the color of urine may darken.
Due to the presence of sucrose in the composition of the drug, it cannot be used in case of fructose intolerance, mal absorption syndrome / galactose, or sucrose-isomaltase deficiency (rare metabolic disorders).
Application in pediatrics
This dosage form is not prescribed for children under 6 years of age.
Application during pregnancy and lactation
The drug Gyno-Tardyferon® is used during pregnancy and lactation according to indications.
Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous mechanisms
Does not affect.
Taking the recommended doses of the drug cannot lead to an overdose of Gyno-Tardiferon®. However, there have been some cases of overdose in children after accidental ingestion of a large amount of the drug.
Symptoms: irritation and necrosis of the gastrointestinal tract, in most cases accompanied by nausea, vomiting and a state of shock
Treatment: raw eggs and milk should be taken orally, which will ensure the binding of iron ions in the gastrointestinal tract and their subsequent excretion
– if the drug has been recently taken, it can be removed from the stomach, causing the patient to vomit
– gastric lavage using 1% aqueous sodium bicarbonate solution or prescribe deferoxamine
– symptomatic therapy
Folic acid overdose is impossible due to its low content in the preparation.
Store at temperatures up to 25 ° C
Keep out of the reach of children!
Shelf life – 3 years
Do not use after the expiration date printed on the package